Introduction
The mAb Sector Analysis Tool presents the marketed and R&D portfolios, technology focus and product development strategies of over 100 key players in the mAbs market. In addition, you can to view, interrogate and tailor six-year sales forecasts for mAb products due to launch by 2010. This Sector Analysis Tool complements Monoclonal Antibody Therapies: Evolving into a $30 billion market (DMHC2069).
Key reasons to read this report
- Access data on the leading mAb products, technologies and players in the global pharmaceutical market analyzing current and future trends
- Compare players by global forecast therapy area sales and portfolio breakdown measures to identify winners and losers to 2010
- Drill down to individual drug forecasts and descriptions, identifying the key drivers behind forecast performance over the next six years
